Creative Medical Technology Holdings Inc (NASDAQ:CELZ) shares, rose in value, with the stock price up by 3.45% to the previous day’s close as strong demand from buyers drove the stock to $2.97.
Actively observing the price movement in the recent trading, the stock is buoying the session at $2.87, falling within a range of $2.9 and $3.13. The value of beta (5-year monthly) is 4.906. Referring to stock’s 52-week performance, its high was $6.90, and the low was $1.69. On the whole, CELZ has fluctuated by 22.69% over the past month.
With the market capitalization of Creative Medical Technology Holdings Inc currently standing at about $7.68 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-09.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CELZ’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of CELZ currently trading nearly 12.71% and 28.37% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 56.57, while the 7-day volatility ratio is showing 16.88% which for the 30-day chart, stands at 11.18%. Furthermore, Creative Medical Technology Holdings Inc (CELZ)’s beta value is 4.94.
A comparison of Creative Medical Technology Holdings Inc (CELZ) with its peers suggests the former has fared considerably weaker in the market. CELZ showed an intraday change of 3.45% in today’s session so far, and over the past year, it grew by 28.53%%.
Data on historical trading for Creative Medical Technology Holdings Inc (NASDAQ:CELZ) indicates that the trading volumes over the past 10 days have averaged 0.3 and over the past 3 months, they’ve averaged 101.59K. According to company’s latest data on outstanding shares, there are 2.58 million shares outstanding.
Nearly 2.02% of Creative Medical Technology Holdings Inc’s shares belong to company insiders and institutional investors own 7.80% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 39554.0 shares as on 2025-06-13, resulting in a short ratio of 0.78. According to the data, the short interest in Creative Medical Technology Holdings Inc (CELZ) stood at 155.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 15949.0. The stock has fallen by -15.41% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CELZ stock heading into the next quarter.
